FindTrial
Sign In

Incidence of postoperative hyperglycemia in non-diabetic patients receiving nerve block with dexamethasone as an adjuvant to ropivacaine

A Prospective Observational Study on Incidence of Postoperative Hyperglycemia in Non-Diabetic Patients Receiving Nerve Block with 8mg of Dexamethasone as an Adjuvant to 0.5 Percentage Ropivacaine - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084059
Enrollment
100
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

SRM medical college hospital and research centre, kattankulathur, potheri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA- I and II Age- 18 to 65 years Patient undergoing nerve block Non-diabetic patients

Exclusion criteria

Exclusion criteria: Diabetic patients Patients who received dns and dextrose solution during study Patients blood sugar less than 80mg/dl Preoperatively

Design outcomes

Primary

MeasureTime frame
To assess the changes in blood glucose level for non-diabetic patients who are undergoing nerve block with dexamethasone using glucometerTimepoint: Blood glucose will be taken six hours and twenty four hours after surgery—

Secondary

MeasureTime frame
To measure the complete blood glucose level before the nerve block with dexamethasone Look for incidence of postoperative nausea and vomiting and duration of pain reliefTimepoint: twenty-four hours after surgery—

Countries

India

Contacts

Public ContactDr K Karthik

SRM medical college hospital and research centre

karthikk1@srmist.edu.in9444586662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026